Clinical and immunologic features of recurrent herpes zoster (HZ) - 15/10/16
for the
Shozu Herpes Zoster Study Group
Abstract |
Background |
Recurrent herpes zoster (HZ) is thought to be rare, but there have been few large-scale studies of recurrent HZ.
Objective |
We conducted a large-scale prospective cohort study to characterize recurrent HZ.
Methods |
We examined 12,522 participants aged 50 years or older in Shozu County and followed them up for 3 years. We compared the incidence of HZ and postherpetic neuralgia, severity of skin lesions and acute pain, cell-mediated immunity, and varicella-zoster virus–specific antibody titer between primary and recurrent HZ.
Results |
A total of 401 participants developed HZ: 341 with primary HZ and 60 with recurrent HZ. Skin lesions and acute pain were significantly milder and the incidence of postherpetic neuralgia was lower in patients aged 50 to 79 years with recurrent HZ than in those with primary HZ. Varicella-zoster virus skin test induced a stronger reaction in patients aged 50 to 79 years with recurrent HZ than in those with primary HZ.
Limitations |
Information on previous HZ episodes was self-reported by participants, so it could not be confirmed that they actually had a history of HZ.
Conclusion |
Recurrent HZ was associated with milder clinical symptoms than primary HZ, probably because of stronger varicella-zoster virus–specific cell-mediated immunity in the patients with recurrence.
Le texte complet de cet article est disponible en PDF.Key words : cell-mediated immunity, humoral immunity, large-scale community-based prospective cohort study, primary herpes zoster, recurrent herpes zoster, varicella-zoster virus
Abbreviations used : CMI, ELISA, HZ, PCR, PHN, VZV
Plan
| Supported by Grants-in-Aid for Scientific Research from the Japanese Ministry of Health, Labor, and Welfare for Research on Publicly Essential Drugs and Medical Devices (fiscal years 2008-2010) [KHC1102] and for Public-Private Sector Joint Research on Publicly Essential Drugs (fiscal year 2011-2012) [KHC1102], and funds from the Research Foundation for Microbial Diseases of Osaka University. |
|
| Conflicts of interest: None declared. |
Vol 75 - N° 5
P. 950 - novembre 2016 Retour au numéro
Article précédent
- Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study
- Kim S. Thomas, Anthony D. Ormerod, Fiona E. Craig, Nicola Greenlaw, John Norrie, Eleanor Mitchell, James M. Mason, Graham A. Johnston, Shyamal Wahie, Hywel C. Williams
- Incidence and prevalence of basal cell carcinoma (BCC) and locally advanced BCC (LABCC) in a large commercially insured population in the United States: A retrospective cohort study
- Gary Goldenberg, Tom Karagiannis, Jacqueline Blanche Palmer, Juzer Lotya, Caitriona O'Neill, Renata Kisa, Vivian Herrera, Daniel M. Siegel
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?